BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q1 financial results
usx:bmy Blog PostBristol-Myers bets on product pipeline to beat patent issues. Is BMY a buy?
usx:bmy usx:ipsc Blog PostCongress Grills Drugmakers: 5 Key Takeaways
usx:jnj usx:pfe usx:bmy usx:mrk usx:abbv usx:azn usx:sny Blog PostInvitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
usx:jnj usx:bmy usx:nvs usx:nvta Blog PostGot $100? Here Are 3 Top Dividend Growth Stocks to Jump-Start Your Portfolio
usx:bmy usx:csco usx:fts Blog Post